GlassScriptPhysician profile
Cassie Burns
NPI 1053608224
$1,440.93
in general payments reported to CMS, 2019-2025
25 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $120 · 2021: $97.43 · 2022: $353 · 2023: $182 · 2024: $165 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.76 | 2022-2025 | Botox, Ubrelvy |
| Nevro Corp. | $134.25 | 2019-2021 | |
| Depuy Synthes Sales INC. | $117.16 | 2022-2023 | Synthecel, Matrixneuro |
| Medtronic, INC. | $115.05 | 2021-2024 | Synchromedii |
| Boston Scientific Corporation | $106.45 | 2019-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $85.75 | 2025 | Prospera |
| Abbott Laboratories | $84.59 | 2019-2025 | Eterna |
| Medtronic USA, INC. | $75.02 | 2019-2020 | |
| Lemaitre Vascular, INC. | $58.88 | 2022-2025 | Anastoclip Gc 8cm (Medium) |
| Baxter Healthcare | $58.11 | 2019-2021 | |
| Flowonix Medical Incorporated | $27.31 | 2019 | |
| Averitas Pharma INC. | $25.49 | 2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $22.75 | 2023 | Xtampza |
| Kls-Martin L.P. | $22.50 | 2023 | |
| Merz Pharmaceuticals, LLC | $19.45 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $18.75 | 2024 | Movantik |
| Pfizer INC. | $17.70 | 2021 | |
| Radius Health, INC. | $15.53 | 2024 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $14.75 | 2022 | |
| Irras USA, INC. | $14.01 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.96 | 2019 | |
| Spinal Simplicity, LLC | $13.72 | 2025 | Ha Minuteman G3-R |
| Davol INC. | $13.72 | 2020 | |
| Stimwave Technologies Incorporated | $11.39 | 2020 | |
| Stryker Corporation | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassie Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.